Gil Schwartzberg - Dec 31, 2021 Form 5 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director, 10%+ Owner
Signature
/s/ Gil Schwartzberg
Stock symbol
LIXT
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/14/2022, 07:48 PM
Previous filing
Jul 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIXT Common Stock Gift $0 -15K -6.05% $0.00 233K Aug 3, 2021 Direct F1, F2
transaction LIXT Common Stock Gift $0 -10K -4.3% $0.00 223K Aug 17, 2021 Direct F1, F2
transaction LIXT Common Stock Gift $0 -7K -3.14% $0.00 216K Sep 3, 2021 Direct F1, F2
holding LIXT Common Stock 106K Dec 31, 2021 By Continuum Partners, L.P.
holding LIXT Common Stock 187K Dec 31, 2021 By Julie Schwartzberg Trust
holding LIXT Common Stock 376K Dec 31, 2021 By Gil & Debbie Schwartzberg Family Trust, Gil Schwartzberg Separate Property
holding LIXT Common Stock 192K Dec 31, 2021 By David N. Sterling Trust
holding LIXT Common Stock 16.7K Dec 31, 2021 By Savannah Sterling Trust
holding LIXT Common Stock 16.7K Dec 31, 2021 By Amanda Sterling Trust
holding LIXT Common Stock 16.7K Dec 31, 2021 By Daniel Sterling Trust
holding LIXT Common Stock 16.7K Dec 31, 2021 By Charles Sterling Trust
holding LIXT Common Stock 33.3K Dec 31, 2021 By Julie Forman 2013 Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Donation to charity.
F2 The shares do not include derivative securities of the Reporting Person that have been reported on the Reporting Person's Forms 3 and 4.